Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem Concentration in Plasma and Subcutis in ECMO Patients
2015-000218-23Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of meropenem in bacterial disease, sponsored by Aarhus University Hospital. Primary endpoint: Time above MIC in plasma and subcutis. Started Mar 2015; status: completed.
02
Drugs
meropenem
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2015-000218-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000218-23.